New sutureless valve to treat aortic stenosis

Written by: Dr. Xavier Ruyra Baliarda
Edited by: Noelia Pino García

The aortic valve is one of the four valves in the heart there. When the heart beats, this valve must be opened properly so that blood flow throughout the body.

Aortic stenosis, severe obstruction of this valve, it is very common in elderly patients. It has a poor prognosis with medical treatment, with an estimated mortality of 25% per year and 50% at two years of the onset of symptoms.

Over the past 40 years, cardiac surgery , valvular has shown very satisfactory results both short and long term, even in very old patients. Still, up to 30% of patients affected by this disease have never been referred for surgical treatment. In most cases because your doctor believes the risk is too high for conventional surgery. These patients are very important factors, such as kidney failure, strokes or previous reoperations, and also are in a situation of significant "fragility" risk.

To provide the best treatment option, it is very important to conduct a full and individual evaluation of each patient (comorbidity, adaptability, degree of dependence) by a multidisciplinary group (heart-team).

treatment of aortic stenosis The new treatment with transcatheter heart valves (Tavis) is an alternative to conventional surgery in high risk patients. The results have been good, but some important questions remain as increased neurological complications, the persistence of significant Paravalvular leakage, vascular complications and the high cost of these prostheses resolved.

Sutureless valves (sutureless) have appeared as an alternative to conventional valves and valves transcatheter. Allow to operate safely and with very good results to patients at high risk. The process is faster because less time is spent in surgery, safer (direct vision, resection of pathological native valve) and less surgical aggression thanks to the mini-incisions.

Currently there is a long experience of over nine years of follow-up with more than 20,000 sutureless aortic prosthesis implanted in Europe with excellent results. The group of Dr. Ruyra Baliarda pioneered these new techniques in Spain and has the most experience in the country with more than 300 cases in the last five years.


Edited by Pino Noelia

*Translated with Google translator. We apologize for any imperfection

By Dr. Xavier Ruyra Baliarda
Cardiovascular Disease

He is an eminence of cardiac surgery, Head of the Cardiac Surgery Service of the Germans Trias i Pujol University Hospital and Head of the Vida al Cor Unit of the Cardiovascular Institute of Quirón-Teknon Medical Center. He is one of the foremost experts in mitral valve repair, avoiding having to take anticoagulants, in the operation of Ross, new aortic valves without suture and in the reconstruction surgery of the cardiac cavities. He has also developed multiple surgical techniques.

*Translated with Google translator. We apologize for any imperfection

View Profile

Overall assessment of their patients

TOPDOCTORS utiliza cookies propias y de terceros para facilitar su experiencia como usuario de nuestra web y captar datos estadísticos mediante el análisis de sus datos de navegación. Si usted continúa con la navegación, entendemos que nos ofrece su consentimiento para el uso de cookies. Puede cambiar la configuración de cookies u obtener más información here.